Work

Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer

Year: 2026

Type: review

Source: Nature Reviews Urology

DOI: 10.1038/s41585-026-01172-5

Authors: Sean A. Fletcher, Nicholas A. Pickersgill, Juan C. Osorio, Deaglan J. McHugh, Himanshu Nagar, Thomas Kole, James Janopaul-Naylor, Kristine Lacuna, James A. Eastham, Karim A. Touijer, Jonathan S. Fainberg, Howard I. Scher, Behfar Ehdaie, Matthew C. Dallos, Christopher D. Gaffney

Institutions: Memorial Sloan Kettering Cancer Center, Rockefeller University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7167791839

FWCI:

Cites: 87

Cited by:

Related to: 10